Each year, nearly 1.3 million women are diagnosed with breast cancer worldwide and about two-thirds of these individuals are determined to have hormone sensitive tumors based on the expression of estrogen receptor-alpha (ERα). Here, ESR1 is linked to breast carcinoma.